Nuclear Cardiology

Nuclear cardiology is a cardiology sub-specialty that conducts a wide variety of non-invasive cardiovascular imaging studies, including: myocardial perfusion imaging (nuclear stress testing) to diagnose and control coronary artery disease, radionuclide cineangiograms, and viability studies to determine the severity of myocardial infarction and to evaluate heart function.

Were studies in nuclear cardiology used to evaluate?

• Your heart function • Blood flow to the heart muscle • Lifestyle interventions and medicines • Best possible heart treatments• Whether shortness of breath, chest discomfort or fatigue is caused by heart disease.

A widest range of tests performed under Nuclear Cardiology are   • Myocardial perfusion tests  • Ventricular function studies  • PET scans  • Resting myocardial perfusion scan  • MUGA scans


Modern practices in cardiovascular therapy | Vasodilators | Percutaneous Coronary Intervention (PCI) | Heart Transplant| Application of cardiac progenitor cells | Imaging| Computed Tomography | Cardiac Magnetic Resonance | Nuclear Imaging | Molecular Imaging | Nuclear Cardiology | Hybrid and Fusion Imaging | Cross-Modality and Multi-Modality Imaging Topics

Market Statistics:

The nuclear medicine market is expected to grow at a 9.0 percent compound annual growth rate (CAGR) from USD 4.8 billion in 2021 to USD 7.5 billion in 2026.

This market is divided into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In terms of the nuclear cardiology market, North America has remained ahead of the other regions due to its superior capacity to handle new and highly advanced technologies.

Furthermore, new low-cost technologies like PET and PACS imaging technology will drive up demand for nuclear cardiology devices.